Search Results - "PEREZ, Cherie"

Phase I Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Solid Tumors With Observations in Androgen-Independent Prostate Cancer by PAPANDREOU, Christos N, DALIANI, Danai D, KIM, Jeri, ADAMS, Julian, ELLIOTT, Peter, ESSELTINE, Dixie, PETRUSICH, Alexandria, DIERINGER, Pauline, PEREZ, Cherie, LOGOTHETIS, Christopher J, NIX, Darrell, HONG YANG, MADDEN, Timothy, XUEMEI WANG, PIEN, Christine S, MILLIKAN, Randall E, TU, Shi-Ming, PAGLIARO, Lance

“…To determine the dose-limiting toxicity and maximum-tolerated dose of the proteasome inhibitor bortezomib administered intravenously weekly for 4 every 5…”
Get full text

Platelet-Derived Growth Factor Receptor Inhibitor Imatinib Mesylate and Docetaxel: A Modular Phase I Trial in Androgen-Independent Prostate Cancer by MATHEW, Paul, THALL, Peter F, JONES, Donnah, PEREZ, Cherie, BUCANA, Corazon, TRONCOSO, Patricia, KIM, Sun-Jin, FIDLER, Isaiah J, LOGOTHETIS, Christopher

“…To study the platelet-derived growth factor receptor (PDGFR) inhibitor imatinib mesylate in androgen-independent prostate cancer (AIPC), alone and in…”
Get full text

Predicting Cancer Development in Oral Leukoplakia: Ten Years of Translational Research by Lee, J J, Hong, W K, Hittelman, W N, Mao, L, Lotan, R, Shin, D M, Benner, S E, Xu, X C, Lee, J S, Papadimitrakopoulou, V M, Geyer, C, Perez, C, Martin, J W, El-Naggar, A K, Lippman, S M

“…Our 10-year translational study of the oral premalignant lesion (OPL) model has advanced the basic understanding of carcinogenesis. Although retinoids have…”
Get full text

Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinoma by Pagliaro, Lance C., Perez, Cherie A., Tu, Shi-Ming, Daliani, Danai D.

“…Fluoropyrimidines are known to have modest activity in the treatment of metastatic renal cell carcinoma (RCC). Capecitabine is an orally administered prodrug…”
Get full text

Employing the treatment-free interval of intermittent androgen ablation to screen candidate prostate cancer therapies by Mao, Shifeng, Daliani, Danai D., Wang, Xuemei, Thall, Peter F., Do, Kim-Anh, Perez, Cherie A., Brown, Melissa A., Bouchillon, Kathleen, Carter, Cindy M., Logothetis, Christopher J., Kim, Jeri

“…BACKGROUND Because neither continuous nor intermittent hormonal therapy is curative, we designed a clinical model to screen new drugs for additive or…”
Get full text

Irofulven, a novel inhibitor of DNA synthesis, in metastatic renal cell cancer by AMATO, Robert J, PEREZ, Cherie, PAGLIARO, Lance

“…Irofulven (6-Hydroxymethylacylfulvene, MGI-114) is the first of a new class of anticancer compounds the acylfulvenes which are derived from the natural…”
Get full text

Genetic factors associated with prostate cancer conversion from active surveillance to treatment by Jiang, Yu, Meyers, Travis J., Emeka, Adaeze A., Cooley, Lauren Folgosa, Cooper, Phillip R., Lancki, Nicola, Helenowski, Irene, Kachuri, Linda, Lin, Daniel W., Stanford, Janet L., Newcomb, Lisa F., Kolb, Suzanne, Finelli, Antonio, Fleshner, Neil E., Komisarenko, Maria, Eastham, James A., Ehdaie, Behfar, Benfante, Nicole, Logothetis, Christopher J., Gregg, Justin R., Perez, Cherie A., Garza, Sergio, Kim, Jeri, Marks, Leonard S., Delfin, Merdie, Barsa, Danielle, Vesprini, Danny, Klotz, Laurence H., Loblaw, Andrew, Mamedov, Alexandre, Goldenberg, S. Larry, Higano, Celestia S., Spillane, Maria, Wu, Eugenia, Carter, H. Ballentine, Pavlovich, Christian P., Mamawala, Mufaddal, Landis, Tricia, Carroll, Peter R., Chan, June M., Cooperberg, Matthew R., Cowan, Janet E., Morgan, Todd M., Siddiqui, Javed, Martin, Rabia, Klein, Eric A., Brittain, Karen, Gotwald, Paige, Barocas, Daniel A., Dallmer, Jeremiah R., Gordetsky, Jennifer B., Steele, Pam, Kundu, Shilajit D., Stockdale, Jazmine, Roobol, Monique J., Venderbos, Lionne D.F., Sanda, Martin G., Arnold, Rebecca, Patil, Dattatraya, Evans, Christopher P., Dall’Era, Marc A., Vij, Anjali, Costello, Anthony J., Chow, Ken, Corcoran, Niall M., Rais-Bahrami, Soroush, Phares, Courtney, Scherr, Douglas S., Flynn, Thomas, Karnes, R. Jeffrey, Koch, Michael, Dhondt, Courtney Rose, Nelson, Joel B., McBride, Dawn, Cookson, Michael S., Stratton, Kelly L., Farriester, Stephen, Hemken, Erin, Stadler, Walter M., Pera, Tuula, Banionyte, Deimante, Bianco, Fernando J., Lopez, Isabel H., Loeb, Stacy, Taneja, Samir S., Byrne, Nataliya, Amling, Christopher L., Martinez, Ann, Boileau, Luc, Gaylis, Franklin D., Petkewicz, Jacqueline, Kirwen, Nicholas, Helfand, Brian T., Xu, Jianfeng, Scholtens, Denise M., Catalona, William J., Witte, John S.

“…Men diagnosed with low-risk prostate cancer (PC) are increasingly electing active surveillance (AS) as their initial management strategy. While this may reduce…”
Get full text

Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer by Lippman, Scott M., Lee, J. Jack, Karp, Daniel D., Vokes, Everett E., Benner, Steven E., Goodman, Gary E., Khuri, Fadlo R., Marks, Randolph, Winn, Rodger J., Fry, Willard, Graziano, Stephen L., Gandara, David R., Okawara, Gordon, Woodhouse, Charles L., Williams, Brendell, Perez, Cherie, Kim, Hyung W., Lotan, Reuben, Roth, Jack A., Hong, Waun Ki

“…Background: Promising data have suggested that retinoid chemoprevention may help to control second primary tumors (SPTs), recurrence, and mortality of stage I…”
Get full text

A pilot study of thalidomide in patients with progressive metastatic renal cell carcinoma by Daliani, Danai D., Papandreou, Christos N., Thall, Peter F., Wang, Xuemei, Perez, Cherie, Oliva, Rose, Pagliaro, Lance, Amato, Robert

“…BACKGROUND The highly vascular nature of renal cell carcinoma (RCC) suggests that angiogenesis inhibition may be therapeutic for patients with this disease…”
Get full text

How did you get involved in integrative medicine? by Perez, Cherie

Get more information

Clinical aromatherapy. Part I: An introduction into nursing practice by Perez, Cherie

Get full text

Employing thetreatment-free interval of intermittent androgen ablation to screen candidate prostate cancertherapies by SHIFENG MAO, DALIANI, Danai D, KIM, Jeri, XUEMEI WANG, THALL, Peter F, DO, Kim-Anh, PEREZ, Cherie A, BROWN, Melissa A, BOUCHILLON, Kathleen, CARTER, Cindy M, LOGOTHETIS, Christopher J

Get full text

The Emergence of Thalidomide in Treating Advanced Renal Cell Carcinoma by Wood, Laura S., Perez, Cherie, Monroe, Dana

“…New treatment for renal cancer and management of adverse effects. [(BNI unique abstract)] 62 references…”
Get full text

Continuing education: The emergence of thalidomide in treating advanced renal cell carcinoma by Wood, Laura S, Perez, Cherie, Monroe, Dana

“…To review standard and investigational treatments in advanced renal cell carcinoma, with a focus on thalidomide. Published articles, conference proceedings,…”
Get full text

Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience by Papadimitrakopoulou, V A, Dimery, I W, Lee, J J, Perez, C, Hong, W K, Lippman, S M

“…To determine the efficacy of the combination of cisplatin, fluorouracil, and high-dose l-leucovorin (PFL) as organ-preserving induction therapy followed by…”
Get more information

Phase II study of carboplatin and edatrexate (10-EdAM) with leucovorin rescue for patients with recurrent squamous cell carcinoma of the head and neck by HUBER, M. H, DIMERY, I. W, BENNER, S. E, LIPPMAN, S. M, MIHRAN SHIRINIAN, ESPARAZ, B, FRENNING, D, GUILLORY-PEREZ, C, WAUN KI HONG

“…Recurrent squamous cell carcinoma of the head and neck is poorly responsive to chemotherapy in most patients; therefore, the development of new approaches is…”
Get full text